1. Market Research
  2. > Pathology Industry

Bladder Cancer Industry, May 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Molecular Diagnostic, Clinical Trial, Biomarker, Cancer Diagnostic, Diagnostic, Oncology, Therapeutics.


 
1-10 of 40 reports for Bladder Cancer

Purchase Reports From Reputable Market Research Publishers

Bladder Cancer Treatment Drugs Markets in China

Bladder Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...

Global Bladder Cancer Partnering 2010 to 2016

Global Bladder Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • May 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Bladder Cancer Treatment Drugs Companies in China

Bladder Cancer Treatment Drugs Companies in China

  • $ 1 800
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Bladder Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions ...

Bladder Cancer Treatment Drugs Industry Forecasts - China Focus

Bladder Cancer Treatment Drugs Industry Forecasts - China Focus

  • $ 1 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Bladder Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing ...

Bladder Cancer Drug Pathway Analyzer

Bladder Cancer Drug Pathway Analyzer

  • $ 2 243
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 133 targeted molecular therapies known to affect more than 219 specific intracellular signaling pathways ...

Target Atlas in Bladder Cancer: A Competitive Outlook

Target Atlas in Bladder Cancer: A Competitive Outlook

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Bladder Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in bladde ...

Bladder Cancer Drug Pipeline Update

Bladder Cancer Drug Pipeline Update

  • $ 2 243
  • Industry report
  • February 2016
  • by Bioseeker

According to the American Cancer Society, bladder cancer is the 6th most common cancer in the U.S. Bladder cancer occurs among both men and women. When found and treated early, the 5 year survival rate ...

Asia-Pacific Bladder cancer Therapeutics & Diagnostics Market- Segmented by type of cancer and geography (2015-2020)

Asia-Pacific Bladder cancer Therapeutics & Diagnostics Market- Segmented by type of cancer and geography (2015-2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

Bladder cancer is a urologic malignancy, arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though ...

Middle East & Africa Bladder Cancer Therapeutics & Diagnostics market - Segmented by type of cancer and geography (2015-2020)

Middle East & Africa Bladder Cancer Therapeutics & Diagnostics market - Segmented by type of cancer and geography (2015-2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though ...

Latin America Bladder  Bladder Cancer Therapeutics & Diagnostics market - Segmented by type of cancer and geography (2015-2020)

Latin America Bladder Bladder Cancer Therapeutics & Diagnostics market - Segmented by type of cancer and geography (2015-2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though ...

About 1 200 reports for Bladder Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Canada

  • January 2016
    35 pages
  • Bladder Cancer  

    Cancer  

    Oncology  

  • Canada  

View report >

Pathology Description

January 2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.